TNFAIP3 and acute lymphoblastic leukemia: We for the first time characterize TNFAIP3 mutation patterns and demonstrate that they mainly occur in adult T‐ALL patients and suggest that TNFAIP3 mutation might be a predictor of adverse clinical outcomes in T‐ALL patients, which might complement current prognostic stratification for T‐ALL patients.